Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic Cannabidiol in Pediatric Treatment-Resistant Childhood Absence Seizures
NCT03336242Phase 2Terminated
- Start
- Dec 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in childhood absence epilepsy (CAE). Started Dec 2017; status: terminated.
02
Drugs
cannabidiol
03
Conditions
childhood absence epilepsy (CAE)
Beyond the preview
Go deeper on NCT03336242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336242.